We’ve long known that diet plays a crucial role in cancers of the liver and pancreas. But could the food we eat also influence lung cancer risk? A groundbreaking study from UF Health and the University of Kentucky reveals a surprising link between the Western diet and lung cancer growth.
Fostering better dietary habits can be a powerful tool in lung cancer prevention.
For cancers of organs like the liver, the long-term impact of our diet has been well studied — so much so that we have guidance about red meat, wine and other delicacies.
A new study from researchers at University of Florida Health looks at another kind of organ whose cancer risk may be affected by poor diet: the lungs. The study was funded by several National Institutes of Health grants and a collaboration between the University of Kentucky's Markey Cancer Center and the UF Health Cancer Center.
“Lung cancer has not traditionally been thought of as a dietary-related disease,” said Ramon Sun, Ph.D., an associate professor and director of the UF Center for Advanced Spatial Biomolecule Research. “Diseases like pancreatic cancer or liver cancer, yes. However, when it comes to lung cancer, the idea that diet could play a role is rarely discussed.”
To the team’s knowledge, this is the first study of the association between lung cancer and poor diet at an NCI-designated cancer center, said study collaborator Matthew Gentry, Ph.D., a professor and chair of biochemistry and molecular biology at the UF College of Medicine.
The team used a high-content spatial metabolomics platform Sun created in 2020.
“This platform offered a new lens through which to visualize diseases, enabling researchers to discern previously undiscovered molecular patterns and interactions with striking detail and depth of insight,” Sun said.
In the case of lung adenocarcinoma, the cancer that accounts for 40 % of lung cancer diagnoses worldwide, the work built off Gentry and Sun’s 20-year study of an ultra-rare condition called Lafora disease.
The neurological disorder has a devastating trajectory. Patients develop seemingly normally for a decade, then present with epilepsy. Dementia ensues, and most patients die before they turn 25 years old.
The new study borrows from how Lafora unfolds, focusing on glycogen accumulation. This storage molecule, made up of glucose, or a simple sugar, has been found to accumulate in high levels across a variety of cancers and other diseases.
Through lab models and computer-guided models of glycogen stores in the lung, the researchers showed that in lung cancer, glycogen acts as an oncogenic metabolite, akin to a “giant lollipop for cancer’s sweet tooth.”
The more glycogen in the cancer cells, the bigger and worse the tumor growth. When scientists fed mice a high-fat, high-fructose “Western diet” that supported more glycogen in the blood, lung tumors grew. When glycogen levels decreased, tumor growth did, too.
In short: The typical Western diet increases glycogen levels and glycogen feeds lung cancer tumors by providing their building blocks for growth. Glycogen is an “exceptionally good predictor” of tumor growth and death in lung cancer patients, Sun said.
Although it’s one of the first instances of lung cancer being linked to diet, it is far from the first time nutrition has been a focal point in cancer prevention and intervention.
“In the long term, our approach to cancer prevention should mirror the success of the anti-smoking campaign — placing greater emphasis on public awareness and policy-driven strategies that promote healthier dietary choices as a fundamental component of disease prevention,” Sun said.
Another benefit of focusing on glycogen is the variety of treatment options available. Currently, three types of drugs target glycogen levels, Gentry said, and all were developed studying Lafora disease.
His takeaway is one you’ve likely heard across a dinner table. “Prioritizing a nutrient-rich diet, maintaining an active lifestyle and minimizing alcohol intake are foundational strategies for long-term health,” Gentry said. “Fostering better dietary habits can be a powerful tool in lung cancer prevention.”
Date: 08.12.2025
Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.
Consent to the use of data for promotional purposes
I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planck-Str. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here
Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.
Additionally, my consent also includes the processing of my email address and telephone number for data matching for marketing purposes with select advertising partners such as LinkedIn, Google, and Meta. For this, Vogel Communications Group may transmit said data in hashed form to the advertising partners who then use said data to determine whether I am also a member of the mentioned advertising partner portals. Vogel Communications Group uses this feature for the purposes of re-targeting (up-selling, cross-selling, and customer loyalty), generating so-called look-alike audiences for acquisition of new customers, and as basis for exclusion for on-going advertising campaigns. Further information can be found in section “data matching for marketing purposes”.
In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here. This does not apply to data matching for marketing purposes.
Right of revocation
I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://contact.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.
Original Article: Glycogen drives tumour initiation and progression in lung adenocarcinoma; Nature Metabolism; DOI:10.1038/s42255-025-01243-8